Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Enterprise Value (2019 - 2026)

Bioceres Crop Solutions' Enterprise Value history spans 11 years, with the latest figure at $14.0 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 64.47% to $14.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $14.0 million, a 64.47% decrease, with the full-year FY2025 number at -$16.1 million, up 74.82% from a year prior.
  • Enterprise Value hit $14.0 million in Q1 2026 for Bioceres Crop Solutions, up from -$16.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for BIOX hit a ceiling of $39.4 million in Q1 2025 and a floor of -$64.0 million in Q2 2024.
  • Historically, Enterprise Value has averaged -$21.0 million across 5 years, with a median of -$27.5 million in 2022.
  • Biggest five-year swings in Enterprise Value: soared 74.82% in 2025 and later plummeted 64.47% in 2026.
  • Tracing BIOX's Enterprise Value over 5 years: stood at -$38.9 million in 2022, then plummeted by 55.01% to -$60.3 million in 2023, then decreased by 6.16% to -$64.0 million in 2024, then soared by 74.82% to -$16.1 million in 2025, then surged by 186.92% to $14.0 million in 2026.
  • Business Quant data shows Enterprise Value for BIOX at $14.0 million in Q1 2026, -$16.1 million in Q2 2025, and $39.4 million in Q1 2025.